The global macular degeneration treatment market size was valued at USD 10.06 billion in 2024 and it is projected to reach ...

Introduction The eye's macula is impacted by macular degeneration, a neurodegenerative condition. Macular degeneration will cause loss of centr ...

DelveInsight's 'Dry Age-Related Macular Degeneration Pipeline Insight 2025' report provides comprehensive global coverage of ...

People who are of European descent may be more at risk of age-related macular degeneration than those of African or Hispanic ...

Age-related macular degeneration (AMD ... This may be a way to stop vision loss from GA without brand-new treatments. Geographic atrophy is a complex disease, and there’s still a lot we don ...

Leerink Partners analyst Marc Goodman has maintained their bullish stance on OPT stock, giving a Buy rating yesterday.Invest with Confidence: ...

Lower rates of both progression of macular fibrosis and intravitreal aflibercept injections were found in those who used the ...

Australia's Therapeutic Goods Administration has approved the use of a new and first treatment for geographic atrophy - a disease which causes severe ...

Kyung Bo Kim discovered compounds that improved cognitive function regardless of amyloid plaque buildup — an encouraging sign ...

Researchers in Scotland are developing a digital tool powered by artificial intelligence that can gauge your risk of ...

The phase 1 clinical trial is a multicenter, open-label, dose-escalation study to assess drug safety via intravitreal ...

A multidisciplinary team of researchers from the Istituto Italiano di Tecnologia (IIT-Italian Institute of Technology) and ...